Aptus Pharma Stock Performance
|
|
|
Aptus Pharma Company background
Founded in: 2010
Managing director: Tejash Maheshchandra Hathi
Aptus Pharma Limited was originally incorporated as Aptus Pharma Private Limited, as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010. Subsequently, Company was converted into a public limited retaining the name as Aptus Pharma Limited and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre.Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements. It provide a diverse range of pharmaceutical products catering to various therapeutic categories including antiinfectives, gastrointestinal, antacids, antiallergic and respiratory, nutritional supplements, pain management, neuropsychiatric, cardiovascular, antidiabetic, lipidlowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.The Company started business through 4 regional headquarters in Gujarat in 2011. It launched a portfolio of nearly 25 products targeting essential therapeutic divisions in 2013. It expanded the operations to over 50 products, catering to both acute and chronic segments in 2015. This resulted the increase in portfolio to 70 products in 2019 and to over 100 in 2022. The Company enhanced the production to over 175 products in 2024. It established 3 operational divisions: Acute, Chronic, and OTC in 2024. Company is planning the Initial Public Issue of 20,00,000 equity shares of face value of Rs 10 each through fresh issue.
Aptus Pharma Share Price Today
As of 7 Mar 2026, Aptus Pharma share price is ₹271.8. The stock opened at ₹271.8 and had closed at ₹266.4 the previous day. During today’s trading session, Aptus Pharma share price moved between ₹271.75 and ₹271.75, with an average price for the day of ₹271.75. Over the last 52 weeks, the stock has recorded a low of ₹80.80 and a high of ₹277.00. In terms of performance, Aptus Pharma share price has declined by 0% over the past six months and has increased by 214.06% over the last year.

View details of Market Depth
Aptus Pharma Fundamental
Market Cap (in crs)
186.42
Face Value
10
Turnover (in lacs)
16.31
Key Metrics
Qtr Change %
67.2
Dividend yield 1yr %
0
Aptus Pharma Technical Analysis
Moving Averages Analysis
271.75
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
0
Day EMA5
266.70
Day EMA10
262.20
Day EMA12
260.70
Day EMA20
254.40
Day EMA26
249.20
Day EMA50
227.00
Day EMA100
179.30
EMA
Delivery & Volume
Loading chart...
Delivery Volume %
Day
100.00%
Week
100.00%
Month
100.00%
Delivery & Volume
Day Rs | 6000 Rs | 6000 Rs |
Week Rs | 9000 Rs | 9000 Rs |
Month Rs | 6823 Rs | 6823 Rs |
Resistance & Support
271.75
Pivot
Resistance
First Resistance
271.75
Second Resistance
271.75
Third Resistance
271.75
Support
First Support
271.75
Second support
271.75
Third Support
271.75
Relative Strength Index
67.83
Money Flow Index
48.46
MACD
11.43
MACD Signal
11.60
Average True Range
6.07
Average Directional Index
28.58
Rate of Change (21)
2.47
Rate of Change (125)
0.00
Aptus Pharma Peer comparison
Compare61.00 -0.73 (-1.18%)▼ | |
25.03 -0.27 (-1.07%)▼ | |
50.60 +0.02 (+0.04%)▲ | |
291.80 +1.80 (+0.62%)▲ | |
45.91 -1.30 (-2.75%)▼ | |
110.20 +0.20 (+0.18%)▲ |
Aptus Pharma Latest News
View More
Aptus Pharma Share Price FAQs
Please be aware that Aptus Pharma stock prices are subject to continuous fluctuations due to various factors.